|Articles|February 1, 2012
- BioPharm International-02-01-2012
- Volume 25
- Issue 2
BioPharm International, February 2012 Issue (PDF)
Investing in BioPharma Outsourcing
Advertisement
Articles in this issue
about 14 years ago
Biomanufacturing Outsourcing Outlookabout 14 years ago
Preparing For the New Chinaabout 14 years ago
What the 2011 Census of India Reveals for Pharmaabout 14 years ago
Saving the Next Generation of Regulatory Scientistsabout 14 years ago
A Risk-Based Approach to Transferring a Mature Biopharmaceutical Processabout 14 years ago
PQRI Case Study: Facility Biocontainment and Inactivationabout 14 years ago
Assessing the Risk of Leachables from Single-Use Systemsabout 14 years ago
Sustainable Investmentabout 14 years ago
Understanding Gamma SterilizationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5
